For everything that has been denied golf fans in this period of quarantine—access to courses for many, the Masters for all, freedom from Peloton updates for an unlucky few— one thing remains soothingly constant among the social media commentariat: begrudgery.
That much was evident with the news that former PGA Tour commissioner Tim Finchem will join Tiger Woods and Marion Hollins in the next class to be inducted into the World Golf Hall of Fame. The announcement was greeted with griping that was as predictable as it is tedious, an exercise in collective eye-rolling intended to suggest not only that Finchem is undeserving but that his inclusion dilutes the Hall’s credibility.
Continue reading “Hall of Fame Has Blind Spots, But Finchem Isn’t One Of Them.”
The Ryder Cup had its share of weekend thrills for fans, but for players the drama began much earlier. Tuesday evening, to be exact. And not at Le Golf National but seven miles away at the Trianon Palace hotel, which was home to both the U.S. and European teams. That’s when officials from the French Anti-Doping Agency (AFLD) arrived unannounced to conduct random drug tests.
The players had reason to be surprised. It was the first time drug tests were administered at a Ryder Cup. That it happened in Paris should be less surprising. The French take their anti-doping laws seriously. That’s why Lance Armstrong now owns as many Tour de France victories as Jack Nicklaus.
Continue reading “Ryder Cup Drug Tests Fuel Rumor Mill”